Cargando…
Pembrolizumab-Associated Hypoparathyroidism: A Single Case Report
OBJECTIVE: To evaluate a case of pembrolizumab-induced hypoparathyroidism leading to hypocalcemia. METHODS: The diagnostic tests performed included calcium and parathyroid hormone level detection and calcium-sensing receptor gene analysis. RESULTS: A 71-year-old Caucasian man was diagnosed with stag...
Autores principales: | Mahmood, Israa, Kuhadiya, Nitesh D., Gonzalaes, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association of Clinical Endocrinology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924152/ https://www.ncbi.nlm.nih.gov/pubmed/33718603 http://dx.doi.org/10.1016/j.aace.2020.11.003 |
Ejemplares similares
-
Effects of concomitant combination of SGLT‐2 inhibitor and GLP‐1 receptor agonist on renal outcomes in T2D with eGFR below 30 and macroalbuminuria: A case series
por: Kuhadiya, Nitesh D., et al.
Publicado: (2021) -
SAT220 Rare Case Of Pembrolizumab Induced Primary Hypoparathyroidism
por: Goud, Sarita G, et al.
Publicado: (2023) -
An interesting case of primary hypoparathyroidism
por: Kirpalani, D. A., et al.
Publicado: (2014) -
Severe hypocalcemia due to hypoparathyroidism associated with HIV: A case report
por: Gulden, Taran, et al.
Publicado: (2021) -
COVID-19 induced hypoparathyroidism: A case report
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2022)